Does DALFAMPRIDINE Cause Injection site discolouration? 21 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Injection site discolouration have been filed in association with DALFAMPRIDINE (Dalfampridine). This represents 0.0% of all adverse event reports for DALFAMPRIDINE.
21
Reports of Injection site discolouration with DALFAMPRIDINE
0.0%
of all DALFAMPRIDINE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Injection site discolouration From DALFAMPRIDINE?
Of the 21 reports.
Is Injection site discolouration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DALFAMPRIDINE. However, 21 reports have been filed with the FAERS database.
What Other Side Effects Does DALFAMPRIDINE Cause?
Gait disturbance (8,780)
Drug ineffective (6,794)
Fall (5,554)
Therapy cessation (4,580)
Fatigue (3,778)
Balance disorder (3,753)
Multiple sclerosis relapse (3,322)
Condition aggravated (3,240)
Dizziness (2,959)
Urinary tract infection (2,757)
What Other Drugs Cause Injection site discolouration?
ETANERCEPT (1,846)
DUPILUMAB (779)
CERTOLIZUMAB PEGOL (597)
ADALIMUMAB (554)
EVOLOCUMAB (476)
GLATIRAMER (270)
EXENATIDE (266)
TERIPARATIDE (249)
ASFOTASE ALFA (243)
ENBREL (231)
Which DALFAMPRIDINE Alternatives Have Lower Injection site discolouration Risk?
DALFAMPRIDINE vs DALTEPARIN
DALFAMPRIDINE vs DAMOCTOCOG ALFA PEGOL
DALFAMPRIDINE vs DANAPAROID
DALFAMPRIDINE vs DANAZOL
DALFAMPRIDINE vs DANICOPAN